Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI148512 (Benzoyl Peroxide 3% Gel) for Acne Vulgaris in Japanese Subjects
NCT01400932Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2011
- Primary completion
- Apr 2012
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of benzoyl peroxide + sulfur in acne vulgaris (2 arms), sponsored by GSK. Primary endpoint: Absolute Change in Total Lesion Counts From Baseline to Week 12. Started Jul 2011; status: completed.
02
Drugs
benzoyl peroxide + sulfur
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01400932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400932.